Recombinant Osteoglycin (OGN)

OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor

  • Recombinant Osteoglycin (OGN) Packages (Simulation)
  • Recombinant Osteoglycin (OGN) Packages (Simulation)
  • RPC688Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Osteoglycin (OGN)

USAGE of the Recombinant Osteoglycin (OGN)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Osteoglycin (OGN)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Osteoglycin (OGN)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
RPC688Ra01 Recombinant Osteoglycin (OGN) Positive Control; Immunogen; SDS-PAGE; WB.
PAC688Ra01 Polyclonal Antibody to Osteoglycin (OGN) WB; IHC; ICC; IP.
LAC688Ra71 Biotin-Linked Polyclonal Antibody to Osteoglycin (OGN) WB; IHC; ICC.
GUESTBOOK